| “Death Panels” for Metastatic Lung Cancer Improve and Extend Life J Temel, J Greer, A Muzikansky JCOM 17 (10), 2010 | | 2010 |
| “How much time do I have?”: Communicating prognosis in the era of exceptional responders TW LeBlanc, JS Temel, PR Helft American Society of Clinical Oncology Educational Book 38, 787-794, 2018 | 63 | 2018 |
| “It’s been a long journey:” A qualitative study of patient and caregiver experiences during multimodality treatment for locally advanced rectal cancer. KS Lau-Min, R Psenka, K Massad, A El-Jawahri, JS Temel, AR Parikh, ... Journal of Clinical Oncology 41 (16_suppl), e24130-e24130, 2023 | | 2023 |
| 1–84 Differences in phenotype and transcriptome distinguish IL-6-mediated versus myostatin-mediated cachexia V Baracos, M Muscaritoli, Z Aversa, FR Fanelli, A Loumaye, M Barsy, ... Journal of Cachexia, Sarcopenia and Muscle 6 (1), 2-31, 2015 | | 2015 |
| 183 Psychotropic Drugs and Medication ML Lloyd-Williams, S Payne, S Murray, TE Quill, AP Abernethy, L Rayner, ... Medicine 368 (13), 1173-1175, 0 | | |
| A Career Changing Trip to Seattle JS Temel Journal of Pain and Symptom Management 63 (6), e661-e662, 2022 | | 2022 |
| A digital therapeutic application (ePAL) to manage pain in patients with advanced cancer: A randomized controlled trial M Kamdar, K Jethwani, AJ Centi, S Agboola, N Fischer, L Traeger, ... Journal of Pain and Symptom Management, 2024 | | 2024 |
| A multicenter phase II trial of adjuvant erlotinib in patients with resected non-small cell lung cancer (NSCLC) and mutations in the epidermal growth factor receptor (EGFR … JW Neal, NA Pennell, BW Goodgame, M Lanuti, RS Heist, AT Shaw, ... Journal of Clinical Oncology 28 (15_suppl), 7078-7078, 2010 | 12 | 2010 |
| A multicenter phase II trial of single-agent cetuximab in advanced esophageal and gastric adenocarcinoma JA Chan, LS Blaszkowsky, PC Enzinger, DP Ryan, TA Abrams, AX Zhu, ... Annals of oncology 22 (6), 1367-1373, 2011 | 126 | 2011 |
| A multicenter, randomized controlled trial of perioperative palliative care surrounding cancer surgery for patients and their family members (PERIOP-PC) RA Aslakson, SV Chandrashekaran, E Rickerson, BN Fahy, FM Johnston, ... Journal of palliative medicine 22 (S1), S-44-S-57, 2019 | 25 | 2019 |
| A multimodal intervention enhances sexual function and quality of life (QOL) in hematopoietic stem cell transplant (HCT) Survivors AR El-Jawahri, S Fishman, J Vanderklish, L Traeger, D Dizon, TR Spitzer, ... Biology of Blood and Marrow Transplantation 24 (3), S252, 2018 | 1 | 2018 |
| A multimodal intervention to enhance sexual function and quality of life (QOL) in hematopoietic stem cell transplant (HCT) survivors. S Fishman, J Vanderklish, DS Dizon, L Traeger, ER Park, YBA Chen, ... Journal of Clinical Oncology 35 (15_suppl), 10013-10013, 2017 | | 2017 |
| A multimodal intervention to enhance sexual function and quality of life (QOL) in hematopoietic stem cell transplant (HCT) survivors. A El-Jawahri, S Fishman, J Vanderklish, L Traeger, DS Dizon, JS Temel Journal of Clinical Oncology 35 (31_suppl), 191-191, 2017 | | 2017 |
| A Patient-Centered Utility Index for Non–Small Cell Lung Cancer in the United States JS Swan, IT Lennes, NN Stump, JS Temel, D Wang, L Keller, K Donelan MDM Policy & Practice 3 (2), 2381468318801565, 2018 | 3 | 2018 |
| A phase I study of erlotinib and hydroxychloroquine in advanced non–small-cell lung cancer SB Goldberg, JG Supko, JW Neal, A Muzikansky, S Digumarthy, P Fidias, ... Journal of Thoracic Oncology 7 (10), 1602-1608, 2012 | 192 | 2012 |
| A phase II study of gefitinib in patients with advanced thyroid cancer NA Pennell, GH Daniels, RI Haddad, DS Ross, LJ Wirth, PH Fidias, ... Journal of Clinical Oncology 25 (18_suppl), 6020-6020, 2007 | 18 | 2007 |
| A phase II study of gefitinib in patients with advanced thyroid cancer NA Pennell, GH Daniels, RI Haddad, DS Ross, T Evans, LJ Wirth, ... Thyroid 18 (3), 317-323, 2008 | 245 | 2008 |
| A phase II study of oxaliplatin, pemetrexed, and bevacizumab in previously treated advanced non-small cell lung cancer RS Heist, P Fidias, M Huberman, B Ardman, LV Sequist, JS Temel, ... Journal of Thoracic Oncology 3 (10), 1153-1158, 2008 | 57 | 2008 |
| A phase II trial of eriotinib in previously untreated elderly patients (>= 70 yrs) with advanced NSCLC: Preliminary results BE Johnson, J Lucca, MS Rabin, TJ Lynch, P Ostier, AT Skarin, J Temel, ... ANNALS OF ONCOLOGY 15, 169-169, 2004 | 10 | 2004 |
| A phase II trial of pazopanib in relapsed/refractory small cell lung cancer (SCLC). L Gandhi, RS Heist, JV Lucca, JS Temel, P Fidias, LK Morse, BE Johnson Journal of Clinical Oncology 30 (15_suppl), 7099-7099, 2012 | 9 | 2012 |
